Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Novartis (United Kingdom) | Researchclopedia

Back to institutions

Novartis (United Kingdom)

Frimleycompany

1,624

Works

219,146

Citations

230

h-index

Top Research Topics

Asthma and respiratory diseases Chronic Obstructive Pulmonary Disease (COPD) Research Inhalation and Respiratory Drug Delivery

Top Researchers

Peter J. Barnes University of Virginia

2,769 works222,652 citationsh-index: 216

Recent Research

The NPR1 agonist antibody XXB750 in heart failure: a phase 2 randomized trial

Scott D. Solomon,John J. V. McMurray,et al.

20260 citations

Respiratory and Cough-Related Research

Allergic Rhinitis and Sensitization

Health Systems, Economic Evaluations, Quality of Life

Receptor Mechanisms and Signaling

Respiratory Support and Mechanisms

Pain Mechanisms and Treatments

Ion Channels and Receptors

Neuropeptides and Animal Physiology

Complement system in diseases

Johann S. de Bono Royal Marsden NHS Foundation Trust

2,486 works134,651 citationsh-index: 160

2,270 works130,005 citationsh-index: 151

David G. Beer University of Michigan

613 works92,170 citationsh-index: 107

Allan H. Young University of Manchester

1,404 works79,215 citationsh-index: 125

Ian M. Adcock Lung Institute

1,172 works59,783 citationsh-index: 126

Indirect treatment comparison of iptacopan versus pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and residual anemia despite C5 inhibitor treatment

Austin Kulasekararaj,Phillip Scheinberg,et al.

20260 citations

Advancing Pharmacometrics in Africa: Insights and Perspectives From the 2025 Pharmacometrics Africa Conference

Babatunde Ayodeji Adeagbo,Innocent G. Asiimwe,et al.

20260 citations

Evaluating the cost-effectiveness of dabrafenib and trametinib for the treatment of paediatric patients with a BRAF V600E mutation low-grade glioma in England and Wales.

Rafia Rafia,Munna Ibrahim,et al.

20260 citations

The LuxAR-02 phase II study of luxdegalutamide in combination with [ <sup>177</sup> Lu]Lu-PSMA-617 in patients with prostate-specific membrane antigen (PSMA)–positive metastatic castration resistant prostate cancer (mCRPC).

Daniel P. Petrylak,Phillip H. Kuo,et al.

20260 citations

TulmiSTAR-02: A phase I/II open-label study of dose escalation and expansion of tulmimetostat in combination with darolutamide versus darolutamide, and tulmimetostat with abiraterone in patients with metastatic hormone-sensitive prostate cancer (mHSPC).

Neal D. Shore,Karim Fizazi,et al.

20260 citations